SC: GUVNL Cannot be Guided by its Own Commercial Interests  ||  Bombay High Court to Get New Bench at Kolhapur District  ||  SC: Employers Must Accommodate Workers Who Acquire Disability  ||  Supreme Court Quashes Bail Condition Forcing Conjugal Life With Wife  ||  SC Clarifies: MSME Protection Not Automatic Against SARFAESI  ||  Rajasthan HC Urges Amendment: Tribal Women Barred from Inheritance Under Hindu Succession Act  ||  Rajasthan HC: School Certificate Alone Not Proof of Victim's Age  ||  NIA Court: Court Rejects Claim ATS Tried to Frame RSS Chief in Malegaon Case  ||  Rajasthan HC: Prior Sanction No Shield Against Strong Prima Facie Evidence  ||  Patna High Court: Claim of Juvenility Can be Raised Before Any Court, at Any Stage    

SEBI Imposes Rs. 22 Crore fine on Aurobindo Pharma for Insider Trading - (24 Sep 2019)

CAPITAL MARKET

Securities and Exchange Board of India has imposed a fine of Rs. 22.7 crore on Aurobindo Pharma Ltd., its promoters and related entities for insider trading between July, 2008 to March, 2009.

Tags : SECURITIES AND EXCHANGE BOARD OF INDIA   AUROBINDO PHARMA LTD.  SEBI  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved